DK0744957T3 - Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A - Google Patents

Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A

Info

Publication number
DK0744957T3
DK0744957T3 DK95909729T DK95909729T DK0744957T3 DK 0744957 T3 DK0744957 T3 DK 0744957T3 DK 95909729 T DK95909729 T DK 95909729T DK 95909729 T DK95909729 T DK 95909729T DK 0744957 T3 DK0744957 T3 DK 0744957T3
Authority
DK
Denmark
Prior art keywords
inflammation
preparation
immunoglobulin
prevention
treatment
Prior art date
Application number
DK95909729T
Other languages
English (en)
Inventor
Martha Prof Eibl
Herrmann Dr Wolf
Josef W Mannhalter
Heinz Dr Leibl
Yendra Dr Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22731867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0744957(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of DK0744957T3 publication Critical patent/DK0744957T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95909729T 1994-02-18 1995-02-16 Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A DK0744957T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19806794A 1994-02-18 1994-02-18
PCT/EP1995/000571 WO1995022350A1 (en) 1994-02-18 1995-02-16 Composition and method for preventing and treating inflammation with immunoglobulin a

Publications (1)

Publication Number Publication Date
DK0744957T3 true DK0744957T3 (da) 2000-03-06

Family

ID=22731867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95909729T DK0744957T3 (da) 1994-02-18 1995-02-16 Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A

Country Status (12)

Country Link
US (1) US5833984A (da)
EP (1) EP0744957B1 (da)
JP (1) JPH09509164A (da)
AT (2) ATE182793T1 (da)
AU (1) AU1809495A (da)
CA (1) CA2183566A1 (da)
DE (2) DE69511245T2 (da)
DK (1) DK0744957T3 (da)
ES (1) ES2135703T3 (da)
GR (1) GR3031691T3 (da)
IT (1) IT1281188B1 (da)
WO (1) WO1995022350A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease
DE19600939C1 (de) * 1996-01-12 1997-08-28 Immuno Ag Verfahren zur Trennung von IgG und IgA
US6344545B1 (en) * 1996-06-14 2002-02-05 Progenics Pharmaceuticals, Inc. Method for preventing HIV-1 infection of CD4+ cells
EP0839915A1 (en) * 1996-11-01 1998-05-06 Institut Suisse De Recherches Experimentales Sur Le Cancer Isrec Secretory immunoglobulin A as a mucosal vaccine delivery system
US20020114802A1 (en) * 1998-02-10 2002-08-22 Tjellstrom Bo Arthur Einar Oral immunoglobulin treatment for inflammatory bowel disease
CA2370268A1 (en) * 1999-04-19 2000-10-26 Richard Weisbart Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
JP2004525077A (ja) * 2000-09-28 2004-08-19 リサーチ　コーポレイション　テクノロジーズ，インコーポレイテッド イムノグロブリンｇ強化血漿画分の経口投与による免疫媒介性疾病の治療
US20020098182A1 (en) * 2000-09-28 2002-07-25 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G
WO2002028430A2 (en) * 2000-10-06 2002-04-11 Richard Weisbart Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
US20040180045A1 (en) * 2001-09-28 2004-09-16 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G
US8273347B2 (en) * 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US20060057223A1 (en) * 2004-09-10 2006-03-16 Dimauro Thomas M Intradiscal production of autologous interleukin antagonist
US20110020291A1 (en) * 2007-11-17 2011-01-27 Debrabrata Banerjee Use of stem cells for wound healing
US8986696B2 (en) 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
CN114894911B (zh) * 2022-03-18 2023-10-24 辽宁成大生物股份有限公司 一种控制牛血清产品质量方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5837285B2 (ja) * 1975-05-29 1983-08-15 カブシキガイシヤ ミドリジユウジ チヨウナイカンセンシヨウチリヨウザイノセイゾウホウホウ
JPS5653622A (en) * 1979-10-09 1981-05-13 Mochida Pharmaceut Co Ltd Preventive and remedy for infectious disease of respiratory organ and oral cavity
JPS5759815A (en) * 1980-09-30 1982-04-10 Mochida Pharmaceut Co Ltd Drug composition having preventing and remedying action on rotavirus infectious disease
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
AT402789B (de) * 1991-03-25 1997-08-25 Immuno Ag Pharmazeutische präparation auf basis von plasmaproteinen

Also Published As

Publication number Publication date
EP0744957A1 (en) 1996-12-04
IT1281188B1 (it) 1998-02-17
EP0744957B1 (en) 1999-08-04
ES2135703T3 (es) 1999-11-01
ATE182793T1 (de) 1999-08-15
ITTO950112A1 (it) 1996-08-17
DE69511245D1 (de) 1999-09-09
CA2183566A1 (en) 1995-08-24
GR3031691T3 (en) 2000-02-29
DE69511245T2 (de) 1999-12-16
US5833984A (en) 1998-11-10
ATA29495A (de) 1997-01-15
ITTO950112A0 (it) 1995-02-17
AU1809495A (en) 1995-09-04
AT402790B (de) 1997-08-25
WO1995022350A1 (en) 1995-08-24
JPH09509164A (ja) 1997-09-16
DE19505287A1 (de) 1995-08-24

Similar Documents

Publication Publication Date Title
DK0744957T3 (da) Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A
FI952327A0 (fi) Ihmisen B-lymfosyytteihin rajoittunutta erilaistumisantigeenia vastaan kimeeristen ja radioleimattujen vasta-aineiden terapeuttinen käyttö B-solulymfooman hoitoon
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
PT914114E (pt) Metodos de tratamento de hipersensibilidade de tipo i utilizando monofosforil lipido a
NZ241210A (en) 16alpha,17alpha-butylidenedioxy-11b, 21-dihydroxypregn-4-ene-3,20-dione derivatives substituted in either or both the 6alpha- and 9alpha- positions by fluorine; pharmaceutical compositions, methods of preparation and treatment
FI970747A0 (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
CA2116562A1 (en) Morphogen-Induced Modulation of Inflammatory Response
DK1059934T3 (da) Matrixproteinpræparater til sårheling
FR2706305B1 (fr) Composition cosmétique ou pharmaceutique anti-radicaux libres pour application topique.
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
IT9067434A0 (it) Procedimento per migliorare l'efficacia terapeutica di corticosteroidi liposolubili e composizione per l'attuazione di tale procedimento
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
DK0579488T3 (da) Præparat til behandling af mastitis og matritis
SE9601395D0 (sv) New therapeutic treatment 1
FI944561A0 (fi) HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV-infektion ehkäisemiseksi ja hoitamiseksi
ATE155345T1 (de) Gegengift immunsera
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
ATE189395T1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
ZA957811B (en) The use of needle-free pressure-actuated injection devices for the administration of active substances to plants
DK0621789T3 (da) Farmaceutiske pentapeptidpræparater og fremgangsmåder til anvendelse deraf
EE03101B1 (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline kompositsioon
ITRM920516A1 (it) Composizione e suo uso per il trattamento terapeutico di affezioni dermatitiche, particolarmente la psoriasi.
UA26326C2 (uk) Спосіб лікуваhhя захворюваhь вірусhої та бактеріальhої етіології у людиhи і твариhи та композиція для його реалізації